Landos Biopharma Inc. (LABP) NASDAQ
$21.82 0.07 (0.32%)
Market Cap: $67.84M
As of 04/19/24 04:00 PM EDT. Market closed.
Landos Biopharma Inc. (LABP)
NASDAQ
$21.82
0.07 (0.32%)
Market Cap: $67.84M
As of 04/19/24 04:00 PM EDT. Market closed.
there is an unmet need for new treatments for autoimmune diseases that transform paradigms and clinical practice. landos will address that unmet clinical need. we know physicians are tired of settling for mediocre therapies for patients living with autoimmune disorders. with one first in class, oral therapy for inflammatory bowel disease (ibd) and its two clinical manifestations: crohn’s ... read more
there is an unmet need for new treatments for autoimmune diseases that transform paradigms and clinical practice. landos will address that unmet clinical need. we know physicians are tired of settling for mediocre therapies for patients living with autoimmune disorders. with one first in class, oral therapy for inflammatory bowel disease (ibd) and its two clinical manifestations: crohn’s disease and ulcerative colitis, showing remarkable preclinical results and entering clinical trials, our team is poised to soon offer ibd patients a better way. the bottom line is this: patients deserve treatment options that are safer, more effective, and less disruptive to their lives. that is what drives landos scientists and our team each and every day. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
RTW INVESTMENTS, LP | 10% Owner | Sep 23, 2022 | Sale | $0.69 | 300,000 | 207,000 | 3,975,722 | Sep 27, 2022, 04:30 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 20, 2021 | Sale | $4.75 | 33,194 | 157,804 | 4,994,208 | Dec 20, 2021, 05:20 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 17, 2021 | Sale | $4.84 | 36,000 | 174,096 | 5,027,402 | Dec 20, 2021, 05:20 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 16, 2021 | Sale | $5.11 | 24,301 | 124,251 | 5,063,402 | Dec 20, 2021, 05:20 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 15, 2021 | Sale | $5.02 | 43,000 | 216,032 | 5,146,354 | Dec 15, 2021, 05:14 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 14, 2021 | Sale | $5.10 | 42,000 | 214,284 | 5,189,354 | Dec 15, 2021, 05:14 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 13, 2021 | Sale | $5.37 | 40,000 | 214,840 | 5,231,354 | Dec 15, 2021, 05:14 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 10, 2021 | Sale | $5.77 | 40,000 | 230,800 | 5,271,354 | Dec 10, 2021, 08:06 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 09, 2021 | Sale | $6.26 | 11,162 | 69,829 | 5,311,354 | Dec 10, 2021, 08:06 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 08, 2021 | Sale | $6.65 | 25,530 | 169,723 | 5,322,516 | Dec 08, 2021, 05:22 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 07, 2021 | Sale | $6.58 | 42,000 | 276,528 | 5,348,046 | Dec 08, 2021, 05:22 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 06, 2021 | Sale | $6.17 | 36,000 | 221,976 | 5,390,046 | Dec 08, 2021, 05:22 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 01, 2021 | Sale | $7.01 | 32,237 | 226,110 | 7,360,915 | Dec 03, 2021, 06:35 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 03, 2021 | Sale | $6.15 | 36,000 | 221,364 | 7,295,054 | Dec 03, 2021, 06:35 PM |
Bassaganya-Riera Josep | 10% Owner | Dec 02, 2021 | Sale | $6.45 | 29,861 | 192,633 | 7,331,054 | Dec 03, 2021, 06:35 PM |
Bassaganya-Riera Josep | 10% Owner | Nov 30, 2021 | Sale | $7.06 | 35,000 | 247,170 | 7,393,152 | Dec 01, 2021, 09:57 PM |
Bassaganya-Riera Josep | 10% Owner | Nov 29, 2021 | Sale | $7.57 | 15,430 | 116,882 | 7,428,152 | Dec 01, 2021, 09:57 PM |
Chauhan Jyoti | ED, Global Clinical Operations | Jul 26, 2021 | Option Exercise | $1.86 | 118,054 | 219,580 | 209,299 | Nov 18, 2021, 04:07 PM |
Poukalov Konstantin | Director | Feb 05, 2021 | Buy | $11.14 | 27,453 | 305,826 | 14,647,181 | Feb 09, 2021, 07:56 PM |
Poukalov Konstantin | Director | Feb 09, 2021 | Buy | $14.08 | 99,681 | 1,403,559 | 14,869,915 | Feb 09, 2021, 07:56 PM |
Poukalov Konstantin | Director | Feb 08, 2021 | Buy | $12.21 | 123,053 | 1,503,061 | 14,770,234 | Feb 09, 2021, 07:56 PM |
PERCEPTIVE ADVISORS LLC | Director | Feb 09, 2021 | Buy | $14.08 | 99,681 | 1,403,559 | 7,299,751 | Feb 09, 2021, 07:20 PM |
PERCEPTIVE ADVISORS LLC | Director | Feb 08, 2021 | Buy | $12.21 | 123,053 | 1,503,061 | 7,200,070 | Feb 09, 2021, 07:20 PM |
PERCEPTIVE ADVISORS LLC | Director | Feb 05, 2021 | Buy | $11.14 | 27,453 | 305,826 | 7,077,017 | Feb 09, 2021, 07:20 PM |
PERCEPTIVE ADVISORS LLC | Director | Feb 08, 2021 | Buy | $16.00 | 1,250,000 | 20,000,000 | 7,049,564 | Feb 08, 2021, 06:37 PM |
Poukalov Konstantin | Director | Feb 08, 2021 | Buy | $16.00 | 1,250,000 | 20,000,000 | 14,619,728 | Feb 08, 2021, 06:08 PM |
RTW INVESTMENTS, LP | 10% Owner | Feb 04, 2021 | Buy | $16.00 | 625,000 | 10,000,000 | 625,000 | Feb 08, 2021, 09:45 AM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 12,604 | 0% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 11,260 | 0.00006% | 9.75% | Other |
BLACKROCK INC. | 42 | 0% | No change | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View